1. Home
  2. ZYXI vs NATR Comparison

ZYXI vs NATR Comparison

Compare ZYXI & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • NATR
  • Stock Information
  • Founded
  • ZYXI 1996
  • NATR 1972
  • Country
  • ZYXI United States
  • NATR United States
  • Employees
  • ZYXI N/A
  • NATR N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NATR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZYXI Health Care
  • NATR Health Care
  • Exchange
  • ZYXI Nasdaq
  • NATR Nasdaq
  • Market Cap
  • ZYXI 265.0M
  • NATR N/A
  • IPO Year
  • ZYXI N/A
  • NATR N/A
  • Fundamental
  • Price
  • ZYXI $8.58
  • NATR $15.00
  • Analyst Decision
  • ZYXI Strong Buy
  • NATR Strong Buy
  • Analyst Count
  • ZYXI 2
  • NATR 2
  • Target Price
  • ZYXI $14.00
  • NATR $19.50
  • AVG Volume (30 Days)
  • ZYXI 57.9K
  • NATR 42.4K
  • Earning Date
  • ZYXI 10-24-2024
  • NATR 11-07-2024
  • Dividend Yield
  • ZYXI N/A
  • NATR N/A
  • EPS Growth
  • ZYXI N/A
  • NATR 114.95
  • EPS
  • ZYXI 0.15
  • NATR 0.88
  • Revenue
  • ZYXI $193,665,000.00
  • NATR $445,095,000.00
  • Revenue This Year
  • ZYXI $10.70
  • NATR $2.07
  • Revenue Next Year
  • ZYXI $19.78
  • NATR $2.62
  • P/E Ratio
  • ZYXI $55.86
  • NATR $17.44
  • Revenue Growth
  • ZYXI 4.21
  • NATR 1.36
  • 52 Week Low
  • ZYXI $7.15
  • NATR $10.81
  • 52 Week High
  • ZYXI $13.77
  • NATR $21.72
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 55.14
  • NATR 42.45
  • Support Level
  • ZYXI $8.13
  • NATR $14.90
  • Resistance Level
  • ZYXI $8.62
  • NATR $15.88
  • Average True Range (ATR)
  • ZYXI 0.29
  • NATR 0.62
  • MACD
  • ZYXI 0.04
  • NATR -0.21
  • Stochastic Oscillator
  • ZYXI 82.93
  • NATR 5.24

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: